\
&
Contact us
\
&
Contact us
This was 4 months ago
LocationWarsaw, Poland
ProgrammesThe main theme of 2025 edition is Boosting security through EU-based innovation. Five thematic panels will provide the opportunity to discuss how to achieve the identified goals while ensuring European strategic autonomy.
In addition, Commissioner for Home Affairs, Magnus Brunner will hold his first implementation dialogue on the challenges to the EU’s security industry competitiveness and to the uptake of security innovation. This dialogue will be an occasion to identify ways to improve, simplify and facilitate the implementation of the EU policy agenda regarding research and innovation for security.
In more than 50 booths, solutions developed under the Horizon Framework Programmes, the Internal Security Fund and the Border Management and Visa Instrument will illustrate the Conference discussions.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
